Xeris Biopharma Holdings, Inc. (XERS): SCHEDULE 13G/A filed Oct 30, 2026

Form type

SCHEDULE 13G/A

Filing date

Oct 30, 2026

Accession number

0002100119-26-001642

Filer

Xeris Biopharma Holdings, Inc. (CIK 1867096)